A Study of BI 3810944 in Patients With Advanced Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is open to adults with advanced cancer (solid tumours) for whom previous treatment was not successful, or no treatment exists. The study tests different doses of BI 3810944 to find out which doses they can tolerate. Another purpose is to identify the most suitable dose of BI 3810944 and to find out whether it helps people with advanced cancer. BI 3810944 may help fight cancer. Participants get BI 3810944 usually once every 3 weeks. At treatment start, it is given once a week for a short time. Participants may continue to get BI 3810944 as long as they benefit from treatment but no longer than 2 years. During this time, they regularly visit the study site. The first study visits include overnight stays at the hospital. At the visits, study doctors check participants' health, take necessary laboratory tests, and note any unwanted effects. The doctors also regularly check the size of the tumour with imaging methods.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorosły wiek (co najmniej 18 lat)
- •Zaawansowany rak (nowotwór stały), który nie reagował na wcześniejsze leczenie lub brak dostępnego leczenia
- •Liczba poprzednich leczenia systemowego nie powinna przekraczać 3 linii
- •Ogólny stan zdrowia na poziomie pozwalającym na udział w badaniu
- •Prognoza życia co najmniej 3 miesiące
- •Wystarczająca funkcja narządów wewnętrznych
- •Widoczny nowotwór do zmierzenia na obrazach (poza mózgiem)
- •Znany status mutacji genu BRAF przed włączeniem do badania
✗ Disqualifies
- •Aktywny rak mózgu lub przerzuty do mózgu powodujące objawy
- •Zapalenie opon mózgowych spowodowane rakiem
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (7)
University of Louisville
Louisville, United States
Tennessee Oncology, PLLC - Elliston Place Plaza DDU
Nashville, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
University of Virginia Health System
Charlottesville, United States
Cliniques Universitaires Saint-Luc
Brussels, Belgium
UZ Leuven
Leuven, Belgium
Radboud Universitair Medisch Centrum
Nijmegen, Netherlands
Trial contact
Boehringer Ingelheim
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.